Determinants of Oligonucleotide Selectivity of APOBEC3B

APOBEC3B (A3B) is a prominent source of mutation in many cancers. To date, it has been difficult to capture the native protein-DNA interactions that confer A3B's substrate specificity by crystallography due to the highly dynamic nature of wild-type A3B active site. We use computational tools to restore a recent crystal structure of a DNA-bound A3B C-terminal domain mutant construct to its wild type sequence, and run molecular dynamics simulations to study its substrate recognition mechanisms. Analysis of these simulations reveal dynamics of the native A3Bctd-oligonucleotide interactions, including the experimentally inaccessible loop 1-oligonucleotide interactions. A second series of simulations in which the target cytosine nucleotide was computationally mutated from a deoxyribose to a ribose show a change in sugar ring pucker, leading to a rearrangement of the binding site and revealing a potential intermediate in the binding pathway. Finally, apo simulations of A3B, starting from the DNA-bound open state, experience a rapid and consistent closure of the binding site, reaching conformations incompatible with substrate binding. This study reveals a more realistic and dynamic view of the wild type A3B binding site and provides novel insights for structure-guided design efforts for A3B.

[1]  C. Simmerling,et al.  ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. , 2015, Journal of chemical theory and computation.

[2]  Huijue Jia,et al.  AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation , 2012, Nature chemical biology.

[3]  Benjamin Haibe-Kains,et al.  APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation , 2015, Proceedings of the National Academy of Sciences.

[4]  Rommie E. Amaro,et al.  POVME 2.0: An Enhanced Tool for Determining Pocket Shape and Volume Characteristics , 2014, Journal of chemical theory and computation.

[5]  H. Aydin,et al.  Structure-guided analysis of the human APOBEC3-HIV restrictome. , 2014, Structure.

[6]  Lela Lackey,et al.  Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination , 2013, Cell cycle.

[7]  Rommie E. Amaro,et al.  Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B , 2016, Nature Structural &Molecular Biology.

[8]  Rommie E. Amaro,et al.  Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B , 2017, Scientific Reports.

[9]  R. Kohli,et al.  Nucleic acid determinants for selective deamination of DNA over RNA by activation-induced deaminase , 2013, Proceedings of the National Academy of Sciences.

[10]  K Nadassy,et al.  Structural features of protein-nucleic acid recognition sites. , 1999, Biochemistry.

[11]  Michael Emerman,et al.  HIV-1 accessory proteins--ensuring viral survival in a hostile environment. , 2008, Cell host & microbe.

[12]  Jacob D. Durrant,et al.  POVME: an algorithm for measuring binding-pocket volumes. , 2011, Journal of molecular graphics & modelling.

[13]  R. Harris,et al.  DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer , 2016, Genome Biology.

[14]  M. Carpenter,et al.  Crystal Structure of the DNA Deaminase APOBEC3B Catalytic Domain* , 2015, The Journal of Biological Chemistry.

[15]  S. Ranganathan,et al.  Advances in RNA molecular dynamics: a simulator's guide to RNA force fields , 2017, Wiley interdisciplinary reviews. RNA.

[16]  D. Harki,et al.  APOBEC Enzymes as Targets for Virus and Cancer Therapy. , 2017, Cell chemical biology.

[17]  Steven A. Roberts,et al.  An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers , 2013, Nature Genetics.

[18]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[19]  Rommie E. Amaro,et al.  The local dinucleotide preference of APOBEC3G can be altered from 5'-CC to 5'-TC by a single amino acid substitution. , 2013, Journal of molecular biology.

[20]  M. Sundaralingam,et al.  Conformational analysis of the sugar ring in nucleosides and nucleotides. A new description using the concept of pseudorotation. , 1972, Journal of the American Chemical Society.

[21]  Z. Szallasi,et al.  Spatial and temporal diversity in genomic instability processes defines lung cancer evolution , 2014, Science.

[22]  T. Cheatham,et al.  Molecular Modeling of Nucleic Acid Structure , 2001, Current protocols in nucleic acid chemistry.

[23]  Serena Nik-Zainal,et al.  Mechanisms underlying mutational signatures in human cancers , 2014, Nature Reviews Genetics.

[24]  C. Schiffer,et al.  Methylcytosine and Normal Cytosine Deamination by the Foreign DNA Restriction Enzyme APOBEC3A* , 2012, The Journal of Biological Chemistry.

[25]  N. A. Temiz,et al.  APOBEC3B is an enzymatic source of mutation in breast cancer , 2013, Nature.

[26]  Reuben S Harris,et al.  The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer , 2016, Science Advances.

[27]  R. Gordân,et al.  Protein–DNA binding: complexities and multi-protein codes , 2013, Nucleic acids research.

[28]  Jason B. Nikas,et al.  APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma. , 2013, Cancer research.

[29]  H. Matsuo,et al.  Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G , 2008, Nature.

[30]  C. Schiffer,et al.  Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity , 2017, Nature Communications.

[31]  B. Honig,et al.  A hierarchical approach to all‐atom protein loop prediction , 2004, Proteins.

[32]  Thomas J Lane,et al.  MDTraj: a modern, open library for the analysis of molecular dynamics trajectories , 2014, bioRxiv.

[33]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[34]  Z. Xiang,et al.  On the role of the crystal environment in determining protein side-chain conformations. , 2002, Journal of molecular biology.

[35]  C. Swanton,et al.  Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[36]  Claudio N. Cavasotto,et al.  Open challenges in structure-based virtual screening: Receptor modeling, target flexibility consideration and active site water molecules description. , 2015, Archives of biochemistry and biophysics.

[37]  Stefano Piana,et al.  Assessing the accuracy of physical models used in protein-folding simulations: quantitative evidence from long molecular dynamics simulations. , 2014, Current opinion in structural biology.

[38]  A. Gronenborn,et al.  Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity. , 2016, Biochemistry.

[39]  E. Pinatel,et al.  Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines , 2017, Leukemia.

[40]  Ming Li,et al.  Small‐Molecule APOBEC3G DNA Cytosine Deaminase Inhibitors Based on a 4‐Amino‐1,2,4‐triazole‐3‐thiol Scaffold , 2013, ChemMedChem.

[41]  Jan H. Jensen,et al.  PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions. , 2011, Journal of chemical theory and computation.

[42]  C. Schiffer,et al.  A computational analysis of the structural determinants of APOBEC3's catalytic activity and vulnerability to HIV-1 Vif. , 2014, Virology.

[43]  Rebecca M. McDougle,et al.  D316 is critical for the enzymatic activity and HIV-1 restriction potential of human and rhesus APOBEC3B. , 2013, Virology.

[44]  Fumiaki Ito,et al.  DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B , 2015, The Biochemical journal.

[45]  J. Šponer,et al.  Can We Execute Stable Microsecond-Scale Atomistic Simulations of Protein-RNA Complexes? , 2015, Journal of chemical theory and computation.

[46]  E. Baker,et al.  Hydrogen bonding in globular proteins. , 1984, Progress in biophysics and molecular biology.

[47]  J. Šponer,et al.  Refinement of the AMBER Force Field for Nucleic Acids: Improving the Description of α/γ Conformers , 2007 .

[48]  Andreas Schlicker,et al.  Elevated APOBEC3B Correlates with Poor Outcomes for Estrogen-Receptor-Positive Breast Cancers , 2014, Hormones and Cancer.

[49]  Yi Xiao,et al.  RNA Stability Under Different Combinations of Amber Force Fields and Solvation Models , 2010, Journal of biomolecular structure & dynamics.

[50]  Sophia Kossida,et al.  Current state-of-the-art molecular dynamics methods and applications. , 2014, Advances in protein chemistry and structural biology.

[51]  Daniel R Roe,et al.  PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. , 2013, Journal of chemical theory and computation.

[52]  Gordon Cook,et al.  APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma , 2014, Nature Communications.

[53]  Yuan-feng Yang,et al.  High APOBEC3B expression is a predictor of recurrence in patients with low-risk clear cell renal cell carcinoma. , 2015, Urologic oncology.

[54]  P. V. van Diest,et al.  Progressive APOBEC3B mRNA expression in distant breast cancer metastases , 2017, PloS one.

[55]  R. Maul,et al.  A Portable Hot Spot Recognition Loop Transfers Sequence Preferences from APOBEC Family Members to Activation-induced Cytidine Deaminase* , 2009, The Journal of Biological Chemistry.

[56]  M. Carpenter,et al.  Determinants of sequence-specificity within human AID and APOBEC3G. , 2010, DNA repair.

[57]  S. Schneider,et al.  Making the Bend: DNA Tertiary Structure and Protein-DNA Interactions , 2014, International journal of molecular sciences.

[58]  A. Bhagwat,et al.  Functions and Malfunctions of Mammalian DNA-Cytosine Deaminases. , 2016, Chemical reviews.

[59]  N. A. Temiz,et al.  Evidence for APOBEC3B mutagenesis in multiple human cancers , 2013, Nature Genetics.

[60]  Luca Pinello,et al.  An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities , 2018, Nature Biotechnology.

[61]  M. Neuberger,et al.  Altering the spectrum of immunoglobulin V gene somatic hypermutation by modifying the active site of AID , 2010, The Journal of experimental medicine.

[62]  Nicholas M. Luscombe,et al.  Amino acid?base interactions: a three-dimensional analysis of protein?DNA interactions at an atomic level , 2001, Nucleic Acids Res..

[63]  N. Krogan,et al.  First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G. , 2012, ACS chemical biology.

[64]  A. Bhagwat,et al.  Efficient deamination of 5-methylcytosines in DNA by human APOBEC3A, but not by AID or APOBEC3G , 2012, Nucleic acids research.

[65]  Subha Kalyaanamoorthy,et al.  Modelling and enhanced molecular dynamics to steer structure-based drug discovery. , 2014, Progress in biophysics and molecular biology.

[66]  W. Brown,et al.  A fluorescent reporter for quantification and enrichment of DNA editing by APOBEC–Cas9 or cleavage by Cas9 in living cells , 2018, Nucleic acids research.

[67]  R. Harris,et al.  Impact of H216 on the DNA Binding and Catalytic Activities of the HIV Restriction Factor APOBEC3G , 2013, Journal of Virology.

[68]  Rommie E. Amaro,et al.  POVME 3.0: Software for Mapping Binding Pocket Flexibility. , 2017, Journal of chemical theory and computation.

[69]  Holger Gohlke,et al.  The Amber biomolecular simulation programs , 2005, J. Comput. Chem..

[70]  R. Siebert,et al.  Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma , 2015, Leukemia.

[71]  S. Wain-Hobson,et al.  Efficient Deamination of 5-Methylcytidine and 5-Substituted Cytidine Residues in DNA by Human APOBEC3A Cytidine Deaminase , 2013, PloS one.

[72]  V. Pathak,et al.  The Role of Amino-Terminal Sequences in Cellular Localization and Antiviral Activity of APOBEC3B , 2011, Journal of Virology.

[73]  J. Dudley,et al.  APOBECs and virus restriction. , 2015, Virology.

[74]  A. Børresen-Dale,et al.  Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.

[75]  F. J. Luque,et al.  Dynamics of B-DNA on the microsecond time scale. , 2007, Journal of the American Chemical Society.

[76]  Jan H. Jensen,et al.  Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values. , 2011, Journal of chemical theory and computation.

[77]  H. Matsuo,et al.  Two Regions within the Amino-Terminal Half of APOBEC3G Cooperate To Determine Cytoplasmic Localization , 2008, Journal of Virology.

[78]  E. Paquet,et al.  Molecular Dynamics, Monte Carlo Simulations, and Langevin Dynamics: A Computational Review , 2015, BioMed research international.